A metagenomic DNA sequencing assay that is robust against environmental DNA contamination.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
23 Nov 2021
Historique:
entrez: 30 11 2021
pubmed: 1 12 2021
medline: 1 12 2021
Statut: epublish

Résumé

Metagenomic DNA sequencing is a powerful tool to characterize microbial communities but is sensitive to environmental DNA contamination, in particular when applied to samples with low microbial biomass. Here, we present contamination-free metagenomic DNA sequencing (Coffee-seq), a metagenomic sequencing assay that is robust against environmental contamination. The core idea of Coffee-seq is to tag the DNA in the sample prior to DNA isolation and library preparation with a label that can be recorded by DNA sequencing. Any contaminating DNA that is introduced in the sample after tagging can then be bioinformatically identified and removed. We applied Coffee-seq to screen for infections from microorganisms with low burden in blood and urine, to identify COVID-19 co-infection, to characterize the urinary microbiome, and to identify microbial DNA signatures of inflammatory bowel disease in blood.

Identifiants

pubmed: 34845444
doi: 10.1101/2021.11.22.469599
pmc: PMC8629186
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R37 AI051652
Pays : United States
Organisme : NIAID NIH HHS
ID : DP2 AI138242
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008267
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI124237
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI146165
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI133331
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : INV-003145
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI151059
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Nat Commun. 2018 Jun 20;9(1):2412
pubmed: 29925834
Orthop Traumatol Surg Res. 2018 Feb;104(1S):S19-S24
pubmed: 29203432
Gut Microbes. 2020;11(2):217-230
pubmed: 31306081
Ann Intern Med. 1983 Dec;99(6):834-9
pubmed: 6360002
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
Trends Microbiol. 2021 Oct;29(10):930-941
pubmed: 33934980
Eur Urol. 2015 Aug;68(2):173-4
pubmed: 25774008
Sci Transl Med. 2014 Jun 18;6(241):241ra77
pubmed: 24944192
Genome Res. 2017 May;27(5):824-834
pubmed: 28298430
Gut Pathog. 2016 May 26;8:24
pubmed: 27239228
PLoS One. 2013 Dec 06;8(12):e81148
pubmed: 24324667
Microbiome. 2017 Aug 14;5(1):99
pubmed: 28807017
Trends Microbiol. 2019 Feb;27(2):105-117
pubmed: 30497919
Bioinformatics. 2011 Jun 1;27(11):1571-2
pubmed: 21493656
Cell. 2021 Jun 24;184(13):3376-3393.e17
pubmed: 34043940
J R Soc Med. 2002 Feb;95(2):81-3
pubmed: 11823550
Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13336-41
pubmed: 26460048
Nat Commun. 2016 Apr 13;7:11257
pubmed: 27071849
Indian J Med Microbiol. 2013 Oct-Dec;31(4):334-42
pubmed: 24064638
PLoS One. 2021 Apr 5;16(4):e0249668
pubmed: 33819304
BMC Gastroenterol. 2014 Nov 18;14:189
pubmed: 25407511
Cell. 2013 Nov 21;155(5):1178-87
pubmed: 24267896
Nat Microbiol. 2019 Apr;4(4):663-674
pubmed: 30742071
Clin Chem. 2021 Dec 30;68(1):163-171
pubmed: 34718476
Microbiome. 2020 Feb 11;8(1):18
pubmed: 32046792
J Clin Microbiol. 2014 Mar;52(3):871-6
pubmed: 24371246
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Med. 2021 Apr 09;2(4):411-422.e5
pubmed: 33521749
Front Immunol. 2022 Jan 12;12:809937
pubmed: 35095900
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Mol Ecol Resour. 2019 Jul;19(4):982-996
pubmed: 30887686
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18738-18744
pubmed: 31451660

Auteurs

Omary Mzava (O)

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Alexandre Pellan Cheng (AP)

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Adrienne Chang (A)

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Sami Smalling (S)

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Liz-Audrey Djomnang Kounatse (LA)

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Joan Lenz (J)

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Randy Longman (R)

Jill Roberts Center for IBD, Weill Cornell Medicine, Division of Gastroenterology and Hepatology, New York, NY, USA.

Amy Steadman (A)

Global Health Labs, Bellevue, WA, USA.

Mirella Salvatore (M)

Division of Public Health Programs, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Manikkam Suthanthiran (M)

Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, 10065, USA.

John R Lee (JR)

Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, 10065, USA.

Christopher E Mason (CE)

Department of Physiology and Biophysics, Weill Cornell Medical College, New York City, NY, USA.

Darshana Dadhania (D)

Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, 10065, USA.

Iwijn De Vlaminck (I)

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Classifications MeSH